IMI plc (LON:IMI – Get Free Report) shares hit a new 52-week high during trading on Thursday . The company traded as high as GBX 1,979 ($24.36) and last traded at GBX 1,969 ($24.24), with a volume of 621796 shares traded. The stock had previously closed at GBX 1,951 ($24.02).
IMI Price Performance
The company has a debt-to-equity ratio of 68.33, a current ratio of 1.36 and a quick ratio of 0.80. The company has a market cap of £5.07 billion, a PE ratio of 2,036.08, a P/E/G ratio of 1.12 and a beta of 1.08. The company has a 50-day moving average price of GBX 1,816.70 and a two-hundred day moving average price of GBX 1,802.56.
Insiders Place Their Bets
In other IMI news, insider Anne Thorburn purchased 5,000 shares of IMI stock in a transaction that occurred on Friday, November 8th. The stock was purchased at an average price of GBX 1,740 ($21.42) per share, with a total value of £87,000 ($107,103.29). Also, insider Jackie Callaway acquired 857 shares of the stock in a transaction on Monday, November 25th. The shares were acquired at an average price of GBX 1,750 ($21.54) per share, with a total value of £14,997.50 ($18,463.01). Insiders purchased a total of 5,878 shares of company stock worth $10,237,809 in the last 90 days. 1.52% of the stock is owned by company insiders.
About IMI
IMI plc is a specialist engineering company operating in fluid and motion control markets. We combine our deep engineering knowledge with strong applications expertise to develop solutions for the most acute industry problems. We help our customers become safer, more sustainable and more productive. IMI employs around 10,000 people, has manufacturing facilities in 19 countries and operates a global service network.
Read More
- Five stocks we like better than IMI
- Industrial Products Stocks Investing
- Oracle Announces Game-Changing News for the AI Industry
- How to Invest in Blue Chip Stocks
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Why Are These Companies Considered Blue Chips?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for IMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMI and related companies with MarketBeat.com's FREE daily email newsletter.